NCT06994208 Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age.
| NCT ID | NCT06994208 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ente Ospedaliero Ospedali Galliera |
| Condition | Melanoma of Skin |
| Study Type | OBSERVATIONAL |
| Enrollment | 25 participants |
| Start Date | 2025-12-02 |
| Primary Completion | 2027-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 25 participants in total. It began in 2025-12-02 with a primary completion date of 2027-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of the study is to analyse a local cohort of patients aged 18-39 years with melanoma diagnosis in order to determine the prevalence of the disease in this age group. Secondary objectives are the following: * To identify risk factors associated with melanoma in young people. * To characterise the phenotype and dermoscopic features of melanoma in patients aged 18-39 years. * To analyse the relationship between the clinical and histopathological features of melanoma in young people. * To identify the mutational status of B-RAF in the sample of patients analysed.
Eligibility Criteria
Inclusion Criteria: 1. written informed consent 2. age \> 18 years and \< 40 years 3. diagnosis of cutaneous melanoma even non-primary Exclusion Criteria: \-
Contact & Investigator
Sanja Javor
PRINCIPAL INVESTIGATOR
Ente Ospedaliero Ospedali Galliera
Frequently Asked Questions
Who can join the NCT06994208 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 39 Years, studying Melanoma of Skin. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06994208 currently recruiting?
Yes, NCT06994208 is actively recruiting participants. Contact the research team at sanja.javor@galliera.it for enrollment information.
Where is the NCT06994208 trial being conducted?
This trial is being conducted at Genoa, Italy.
Who is sponsoring the NCT06994208 clinical trial?
NCT06994208 is sponsored by Ente Ospedaliero Ospedali Galliera. The principal investigator is Sanja Javor at Ente Ospedaliero Ospedali Galliera. The trial plans to enroll 25 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.